{
  "actions": [
    {
      "acted_at": "2019-09-20", 
      "action_code": "Intro-H", 
      "references": [], 
      "text": "Introduced in House", 
      "type": "action"
    }, 
    {
      "acted_at": "2019-09-20", 
      "action_code": "H11100", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "status": "REFERRED", 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-09-20", 
      "action_code": "H11100", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-09-20", 
      "action_code": "", 
      "committees": [
        "HSWM"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }, 
    {
      "acted_at": "2019-09-23", 
      "action_code": "", 
      "committees": [
        "HSIF"
      ], 
      "references": [], 
      "text": "Referred to the Subcommittee on Health.", 
      "type": "referral"
    }
  ], 
  "amendments": [], 
  "bill_id": "hr4455-116", 
  "bill_type": "hr", 
  "by_request": false, 
  "committee_reports": [], 
  "committees": [
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Energy and Commerce", 
      "committee_id": "HSIF", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "14"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM"
    }, 
    {
      "activity": [
        "referral"
      ], 
      "committee": "House Ways and Means", 
      "committee_id": "HSWM", 
      "subcommittee": "Subcommittee on Health", 
      "subcommittee_id": "02"
    }
  ], 
  "congress": "116", 
  "cosponsors": [
    {
      "bioguide_id": "G000584", 
      "district": "0", 
      "name": "Gianforte, Greg", 
      "original_cosponsor": true, 
      "sponsored_at": "2019-09-20", 
      "state": "MT", 
      "title": "Rep", 
      "withdrawn_at": null
    }
  ], 
  "enacted_as": null, 
  "history": {
    "active": false, 
    "awaiting_signature": false, 
    "enacted": false, 
    "vetoed": false
  }, 
  "introduced_at": "2019-09-20", 
  "number": "4455", 
  "official_title": "To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.", 
  "popular_title": null, 
  "related_bills": [
    {
      "bill_id": "hr3-116", 
      "identified_by": "CRS", 
      "reason": "related", 
      "type": "bill"
    }
  ], 
  "short_title": "BIOSIM Act", 
  "sponsor": {
    "bioguide_id": "S001180", 
    "district": "5", 
    "name": "Schrader, Kurt", 
    "state": "OR", 
    "title": "Rep", 
    "type": "person"
  }, 
  "status": "REFERRED", 
  "status_at": "2019-09-20", 
  "subjects": [
    "Health", 
    "Health care costs and insurance", 
    "Medicare", 
    "Prescription drugs", 
    "Product development and innovation"
  ], 
  "subjects_top_term": "Health", 
  "summary": {
    "as": "Introduced in House", 
    "date": "2019-09-20T04:00:00Z", 
    "text": "Bolstering Innovative Options to Save Immediately on Medicines Act or the BIOSIM Act\n\nThis bill increases Medicare payments for biosimilars for five years. The bill applies to biosimilars for which the average sales price or wholesale acquisition cost is less than that of the reference biological product, as specified."
  }, 
  "titles": [
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "To amend title XVIII of the Social Security Act to provide for a temporary payment increase under the Medicare program for certain biosimilar biological products to encourage the development and use of such products.", 
      "type": "official"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "BIOSIM Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "BIOSIM Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Bolstering Innovative Options to Save Immediately on Medicines Act", 
      "type": "short"
    }, 
    {
      "as": "introduced", 
      "is_for_portion": false, 
      "title": "Bolstering Innovative Options to Save Immediately on Medicines Act", 
      "type": "short"
    }, 
    {
      "as": null, 
      "is_for_portion": false, 
      "title": "BIOSIM Act", 
      "type": "display"
    }
  ], 
  "updated_at": "2020-11-10T04:45:21Z", 
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr4455.xml"
}